ClinicalTrials.Veeva

Menu
T

The Movement Disorder Clinic of Oklahoma | Tulsa, OK

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Carbidopa
ABBV-951
Levodopa
PF-06649751
APL-130277
Prasinezumab
Apokyn
SEP-363856
IPX203
IPX066

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 23 total trials

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease (BeyoND)

This is a multi-center, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa (LD/CD) delivered via a pump system as a...

Active, not recruiting
Parkinson's Disease
Drug: ND0612

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab...

Active, not recruiting
Parkinsons Disease
Drug: Placebo
Drug: Prasinezumab

This multicenter, randomized, double-blind, placebo-controlled, Phase 2 study will evaluate the efficacy of intravenous prasinezumab (RO7046015/PRX00...

Active, not recruiting
Parkinson's Disease
Drug: RO7046015
Drug: Placebo

This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy

Active, not recruiting
Multiple System Atrophy
Drug: ATH434 dose level 2
Drug: ATH434 dose level 1

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot fr...

Active, not recruiting
Parkinson's Disease (PD)
Drug: ABBV-951

Trial sponsors

AbbVie logo
Roche logo
I
I
Pfizer logo
Sumitomo Pharma logo
A
E
I
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems